Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma

Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma Holly Leigh Singletary, MD; M. Angelica Selim, MD; Elise Olsen, MD; Departments of Dermatology (Drs Singletary, Selim, and Olsen) and Pathology (Dr Selim), Duke University Medical Center, Durham, North Carolina Herein we report a case of recalcitrant cutaneous pseudo- lymphoma (CPL) treated with subcutaneous interferon. REPORT OF A CASE An otherwise healthy 28-year-old white woman had on- set of skin disease in 2001 when she developed red, ten- der pruritic nodules on her right ear and preauricular area. She had no history of an arthropod bite and was not tak- ing any medications. Results of a biopsy of one of the nod- ules suggested pseudolymphoma. She was treated with clo- betasol propionate, a class I topical corticosteroid, and had complete resolution of the lesions. Three years later, she presented with diffuse erythematous papules and an ery- thematous well-circumscribed plaque on the palm, which were preceded by sore throat, muscle aches, and fever. Re- sults of a biopsy of a specimen from the back showed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma

Loading next page...
 
/lp/american-medical-association/subcutaneous-interferon-alfa-for-the-treatment-of-cutaneous-zbJgleNzDi

References (9)

Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2011.1016
pmid
22782150
Publisher site
See Article on Publisher Site

Abstract

THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma Holly Leigh Singletary, MD; M. Angelica Selim, MD; Elise Olsen, MD; Departments of Dermatology (Drs Singletary, Selim, and Olsen) and Pathology (Dr Selim), Duke University Medical Center, Durham, North Carolina Herein we report a case of recalcitrant cutaneous pseudo- lymphoma (CPL) treated with subcutaneous interferon. REPORT OF A CASE An otherwise healthy 28-year-old white woman had on- set of skin disease in 2001 when she developed red, ten- der pruritic nodules on her right ear and preauricular area. She had no history of an arthropod bite and was not tak- ing any medications. Results of a biopsy of one of the nod- ules suggested pseudolymphoma. She was treated with clo- betasol propionate, a class I topical corticosteroid, and had complete resolution of the lesions. Three years later, she presented with diffuse erythematous papules and an ery- thematous well-circumscribed plaque on the palm, which were preceded by sore throat, muscle aches, and fever. Re- sults of a biopsy of a specimen from the back showed

Journal

JAMA DermatologyAmerican Medical Association

Published: May 1, 2012

There are no references for this article.